Biotech Week articles from August 2004

Biotech Week archives from August 2004

Sexual behavior changes may explain rising incidence of anal cancer.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Anal cancer is on the rise in both sexes, particularly among American men, and changing trends in sexual behavior - combined with current tobacco use and infection by a specific strain of the human...

Study: Squalamine effective for extraretinal neovascularization.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Genaera Corp. (GENR) announced the publication of a study describing the potential use of its antiangiogenic drug, squalamine, to prevent and reduce extraretinal neovascularization associated with...

Inverted pathogenicity useful for prevention or therapy of disease.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Inverted pathogenicity is finding use for the prevention or therapy of disease. "The term 'inverted pathogenicity' stands for the exploitation of microbial toxins, virulence factors, and cellular...

Patent issued for development of HIV/AIDS drug.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Phoenix Biosciences, Inc., (PBS), focused on developing affordable, non-toxic treatments for HIV/AIDS, announced that the U.S. Patent and trademark office has granted PBS Patent Number 6,734,192. ...

Positive results reported on neurodegenerative disease blood test.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Power3 Medical Products, Inc., (PWRM) announced the completion of a stage of clinical validation on their neurodegenerative disease blood test, developed by the company in collaboration with Stan Appel,...

Pharmaceutical group announces that joint venture is operational.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Hubei Pharmaceutical Group (HBEI) announced that its new joint venture, a 60% controlling interest in Hubei Tongji Benda Ebei Pharmaceutical Co. Ltd. (HBBendaJV), located in Guangshui City, Hubei...

FDA approval granted for Aldara for superficial basal cell carcinoma.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- 3M announced that the U.S. Food and Drug Administration (FDA) has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma (sBCC), a type of...

Pharmaceutical firm works to become advanced drug discovery chemistry provider.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- AFID Therapeutics, Inc., announced the launch of the first phase of its campaign to establish itself as the provider of the most advanced drug discovery chemistry in the industry. An array of...

RT-PCR method specifically for European bat lyssavirus 1 developed.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Researchers have developed a hemi-nested RT-PCR method for the specific determination of European bat lyssavirus 1. According to published research from France, "A simplified hemi-nested reverse...

Cardinal Health completes acquisition.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Cardinal Health, Inc., (CAH), a provider of products and services supporting the healthcare industry, announced its previously announced acquisition of ALARIS Medical Systems, Inc., has been completed....

Genedata collaboration creates framework for drug discovery.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Computational biology company Genedata announced the global expansion of its collaboration with ALTANA Pharma to provide enterprise-wide scientific computing infrastructure for ALTANA's research...

Brochure helps lung cancer patients better understand treatment.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- To help patients better understand how radiation therapy is used to fight lung cancer, the American Society for Therapeutic Radiology and Oncology (ASTRO) has published the new patient information...

Species-specific tropism determinants found in the HIV-1 capsid.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Species-specific tropism determinants were found in the HIV-1 capsid. According to a study from the United States, "Retroviral tropism is determined in part by cellular restriction factors that...

FDA grants waived status under CLIA for lipids test panel.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Abaxis, Inc., (ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced that the U.S. Food and Drug Administration has granted waived status under Clinical...

Pharmaceutical firm announces several new appointments.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Able Laboratories, Inc., (ABRX) announced the appointment of Lisa Graver as senior patent counsel working in Able's research & development department. Also, Able announced the appointments of Laura...

CombiMatrix announces human drug metabolism array.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Acacia Research Corp.'s (CBMX) CombiMatrix group has made available to researchers a new CustomArray Human Drug Metabolism Array. This array enables researchers to screen a panel of genes and...

CombiMatrix inks comarketing agreement.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Acacia Research Corp. (CBMX) announced its CombiMatrix group has entered into a comarketing agreement with Strand Genomics to market its product avadis, a data analysis software tool for microarray gene...

First in series of catalog expression arrays launched.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Acacia Research Corporation (CBMX, ACTG) announced that its CombiMatrix group has made available to researches a new CustomArrayHuman Drug Metabolism Array. This array enables researchers to screen...

Flow cytometric method used to assess lipid accumulation in fat cells.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Researchers have used a simple flow cytometric method to assess lipid accumulation in fat cells. "Adipogenesis of preadipocytes in culture has been frequently used to study the molecular basis and...

Real-time qPCR more sensitive than COBAS Amplicor for CMV DNA detection.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- A real-time quantitative PCR assay is more sensitive than the COBAS Amplicor assay for cytomegalovirus (CMV) DNA detection. According to a study from Sweden, "A duplex quantitative real-time PCR...

David Lawrence named CFO at UK pharmaceutical firm.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Acambis plc (ACM, ACAM) announced the appointment of David Lawrence as chief financial officer. Lawrence, 41, is currently VP of finance for Chiron Vaccines, the vaccines division of Chiron...

HSP70 mutants separate antigen delivery from DC stimulation.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- HSP70 peptide binding mutants separate antigen delivery from dendritic cell (DC) stimulation. "Microbial heat shock proteins (HSPs) have been implicated in the induction of both the innate and...

Michael N. Avallone named CFO at pharmaceutical firm.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Advanced Magnetics, Inc., (AVM) announced the appointment of Michael N. Avallone, CPA, as chief financial officer of the company. Avallone will be assuming the responsibilities of James A....

Device firm reports results of tender offer for its notes.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Advanced Medical Optics, Inc., (AMO, AVO) announced the final results of its offer to purchase for cash any and all of the $70,000,000 aggregate outstanding principal amount of its 9-1/4% senior...

Wound care company reports new partnership agreement.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Advanced Medical Solutions (AMS) has entered into a 3-year agreement with Cardinal Health, a provider of products and services supporting the healthcare industry in the United States, for private label...

PC12 cells require dystrophin Dp71 for neurite outgrowth.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- PC12 cells require dystrophin Dp71 for neurite outgrowth. "To determine the role of Dp71 in neuronal cells, we generated PC12 (pheochromocytoma) cell lines in which Dp71 protein levels were...

Australian biotech firm wins grant for ThromboView.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Brisbane-based biotechnology company, Agenix Limited (AGX, AGXLY) announced that its wholly owned subsidiary Agen Biomedical Limited has been awarded a $1,128,758 Australian Government R&D Start grant....

Biotech company names Martha Vincent VP, clinical R&D.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Agensys, Inc., announced the appointment of Martha Vincent, PhD, FACCP, as VP, Clinical Research and Development. Vincent brings extensive expertise in clinical, regulatory and medical affairs to...

Female literacy influences child health in India.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Female literacy influences child health in India. "The influence of female literacy as a major factor affecting child health in India was examined using data from the second National Family Health...

New product removes high-abundance proteins from mouse blood serum.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Agilent Technologies, Inc., (A) introduced the second in a new line of proteomics products that removes high-abundance proteins from blood serum. The Multiple Affinity Removal Column removes the...

Cdx2 is present in early gastric cancers.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic...

Space tech captures toxic micro-organisms.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Sophisticated technology developed to ensure clean air for astronauts onboard space stations is now used in hospitals to capture and destroy airborne fungi, bacteria, spores and viruses. It can also...

Diagnostics device company ships 500th MetriScan densitometer.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Alara, Inc., announced that it has shipped the 500th MetriScan peripheral bone densitometer. MetriScan is a cost-effective, tabletop system that facilitates in-office bone mineral density (BMD)...

Imaging agent launched for preclinical computed tomography.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Alerion Biomedical, Inc., a company developing diagnostic and therapeutic products based on its molecular targeting technologies, has launched Fenestra, its first contrast enhancement product line for...

Court finds Ormco Corp. infringed on teeth straightening patents.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Align Technology, Inc. (ALGN), inventor of Invisalign, a method of straightening teeth without wires and brackets, announced that the U.S. District Court has granted summary judgment in Align's...

Ophthalmic drug company debuts with $26.75M in series A financing.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Alimera Sciences, Inc., a recently formed specialty pharmaceutical company focused on the ophthalmic industry, announced that it has received $26.75 million in Series A financing. The funds will be...

Pharmaceutical company announces retirement of board member.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Allergan, Inc., (AGN) announced that for personal health reasons, Ronald M. Cresswell has retired as a director of Allergan, effective July 9, 2004. "Since joining Allergan's board of directors in...

R. Brian Hanson joins diagnostic imaging company as VP and CFO.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Alliance Imaging Inc. (NYSE:AIQ) announced that R. Brian Hanson will become its executive vice president and chief financial officer. Hanson has extensive financial and operations experience. Most...

Agreement with Nycomed for development of Oxygent terminated.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Alliance Pharmaceutical Corp. (ALLP) announced that Nycomed, its development partner for Oxygent in the European Union, has provided notice that it is terminating the recently announced license...

Biopharmaceutical R&D company announces management changes.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Alltracel Pharmaceuticals Plc. announced the promotion of Tony Richardson from group chief financial officer to group chief executive officer, and John Kelly was appointed to chief financial officer....

Agreement signed for Kadian in cancer pain.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Alpharma, Inc., (ALO) announced that it has entered into a 3-year agreement with MGI Pharma, Inc., an oncology focused biopharmaceutical company, for the promotion of Alpharma's Kadian product, a...

Group supports Medicare reimbursement for brain scans.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- In the hope that it will drive early intervention for the increasing number of Americans with Alzheimer disease, the Alzheimer's Foundation of America (AFA) announced its support of the federal...

Definitive agreement signed to acquire Laxdale.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Amarin Corporation plc (AMRN) announced that it has signed a definitive agreement to acquire Laxdale Limited, a privately owned, neuroscience development company based in Stirling, Scotland. ...

Diagnostics maker announces successful connectivity trial.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Ambri Limited (ABI) announced that it has completed testing of a Data Management System (DMS) - making it the first medical diagnostic device in Australia, and one of the first in the world, to...

Ankle sprains can hide more serious condition.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- A frequent malady of summer activity is a sprained ankle, which sports-medicine experts from the American College of Foot and Ankle Surgeons (ACFAS) said is by far the most neglected injury in the U.S....

Academy reacts to FDA alert on allergic reactions to pigment in permanent makeup.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- In response to the FDA's consumer alert regarding permanent makeup pigments that have been reported to cause severe allergic reactions, the American Academy of Micropigmentation wants consumers to...

New guidelines released for management of hyperbilirubinemia in newborns.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- The American Academy of Pediatrics (AAP) has released new guidelines for the treatment of neonatal jaundice. The guidelines were promulgated by the AAP Subcommittee on Hyperbilirubinemia and...

Guideline challenges use of common medication.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- A new evidence-based guideline for pulmonary arterial hypertension (PAH) cautions the use of calcium channel blockers, a commonly used treatment for high blood pressure, in unstable patients due to the...

Alan D. Cherrington elected president of diabetes group.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- The American Diabetes Association, the nation's largest and leading voluntary health organization in the fight against diabetes, has announced that Alan D. Cherrington, PhD, of Nashville, Tennessee, was...

More intensive cholesterol treatment an option for high-risk heart patients.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- More intensive cholesterol treatment is an option for people at high risk for heart attack and death from cardiovascular disease, according to updated recommendations from the National Cholesterol...

Medical students react to study findings that link nursing errors to long hours.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- The American Medical Student Association (AMSA) has responded to the study, "The working hours of hospital staff nurses and patient safety," published in Health Affairs. The study, led by...

Device firm signs patent cross-licensing agreement with Ethicon.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- American Medical Systems Holdings, Inc., (AMMD) announced that it has entered into a patent cross-licensing agreement with Ethicon, Inc., through its Gynecare Worldwide Division. Under the...

Asthma device maker reports record sales.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- American Scientific Resources, Inc.'s (ASR, ASRO.PK) asthma monitoring device exceeded forecasts and drove ASR to a record quarter. "The product is selling off the pharmacy's shelves just as we are...

Study sets best time for bone marrow transplant in patients with blood disorder.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- "Many MDS patients enjoy a long period after diagnosis without obvious disease progression. For these patients, the risks associated with bone marrow transplantation are unacceptably high," according to...

Maternal anthropometric characteristics impact fetal growth restriction.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Researchers have identified maternal anthropometric characteristics that appear to be risk factors for term or near-term fetal growth restriction (FGR) in uncomplicated pregnancies. Pediatricians...

Joshua Ofman named VP at biotechnology company.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Amgen, Inc., (AMGN) announced the appointment of Joshua Ofman, MD, MSHS, to the new position of vice president, Reimbursement and Payment Policy. Ofman will be responsible for the design and...

Pharmaceutical firm closes $25M equity investment in Orthovita.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Angiotech Pharmaceuticals, Inc., (ANPI, ANP) announced that it has completed its purchase of 5,681,818 common shares of Orthovita, Inc., for $25 million. The equity investment was originally...

Sixth patent granted on fluorescence imaging technology.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- AntiCancer, Inc., of San Diego announced that it has received its sixth patent in a series from the U.S. Patent and Trademark office covering the use of fluorescent proteins for imaging of cancer, gene...

Successful phase Ia trial results reported on anti-obesity compound.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Arena Pharmaceuticals, Inc., (ARNA) announced results from a phase Ia, single-dose clinical trial of the company's novel anti-obesity compound, APD356. APD356 is an orally administered small...

Profoundly deaf children display GJB6 gene deletions.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Profoundly deaf children display GJB6 gene deletions. According to published research from France, "recent investigations identified a large deletion of the GJB6 gene in trans to a mutation of GJB2...

Protein collusion foretells poor prognoses for maxillary sinus cancer patients.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Protein collusion foretells poor prognoses for maxillary sinus cancer patients. "We have previously reported that p53 mutations, loss of bax expression or decreased spontaneous tumor apoptosis were...

Healthcare investment firm hires two key executives.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Asante Partners LLC, an investment banking boutique focused primarily on the healthcare sector, announced that Steven A. Mermelstein has joined the firm as managing director and Brian E. Pasdach has...

North American rights acquired for Andrin.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Ascend Therapeutics announced that it has secured exclusive North American development, marketing and commercialization rights to the developmental pharmaceutical product Andrin (transdermal...

Comments issued on FDA's consumer information release about Glucatell.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Associates of Cape Cod, Inc., (ACC), a manufacturer of endotoxin and beta-glucan detection products, addressed a newly published U.S. Food & Drug Administration (FDA) Consumer Information release...

Insurance companies renew alliance to offer multiple products.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- State Farm Insurance and Assurant Health have renewed the national marketing alliance that makes Assurant Health's individual medical insurance products available through State Farm agents nationwide....

Hundreds of athletes with asthma compete in Athens.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- A diagnosis of asthma used to mean a seat on the bench for amateur and professional athletes. But with advances in asthma treatment and management, asthma - not the athlete - is sent to the...

New methods ease the separation of antisense oligonucleotide in plasma.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- New methods ease the separation of antisense oligonucleotide in plasma. "A novel approach is presented for the direct injection, and subsequent separation, of antisense phosphorothioate...

Psoriasis drug maker's registration statement declared effective by SEC.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Astralis, Ltd., (ASTR) announced that the U.S. Securities and Exchange Commission has declared effective its registration Statement on Form SB-2 covering 47,056,520 shares of common stock (of which...

Sam Barnett, Philippe Magistretti named directors of New Jersey biotech.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Astralis, Ltd., (ASTR) announced the election of Sam Barnett and Philippe Magistretti, MD, to its board of directors. Barnett, a pharmaceutical industry expert, will serve as an independent...

Device maker posts 45% increase in sales.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Austin Medical Technologies, Inc., (AMTK) announced a 45% increase in sales for the second quarter of 2004 over second quarter 2003. Additionally, sales grew in the first quarter of 2004 by 44% over...

Philip Livingston, MD joins advisory board.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Cancer focused bio-pharmaceutical company, Australian Cancer Technology (AustCancer) (ASX:ACU), announced that Professor Philip Livingston has accepted the company's invitation to join its Scientific...

U.S. pharmacy group to distribute nutritional supplement.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Australian Cancer Technology Limited (ACU) announced that its U.S. subsidiary, ACT (USA), has signed a distribution deal with Rochester Drug Cooperative, which will see the revisys range of nutritional...

Studies show Lovenox as an effective treatment of acute coronary syndromes.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Results of two new randomized clinical studies confirm that Lovenox (enoxaparin sodium injection) is an effective and safe antithrombotic agent in patients with non-ST-segment elevation (NSTE) acute...

Enrollment closes in phase III trial with Phenserine.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Axonyx, Inc., (AXYX) announced that it has completed enrollment in the first of its two on-going phase III clinical studies evaluating Phenserine in patients with mild to moderate Alzheimer disease. ...

Antisense transcription of antigen receptor genes involves V region remodeling.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Antisense transcription of antigen receptor genes involves V region remodeling. "Antigen receptor genes undergo variable, diversity and joining(V(D)J) recombination, which requires ordered...

Tentative approval granted for Allegra-D extended-release tablets.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Barr Pharmaceuticals, Inc., (BRL) announced that Barr Laboratories, Inc., has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Aventis...

Role of lactoferrin in iron homeostasis and host defense defined.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Researchers have defined the role of lactoferrin in iron homeostasis and host defense against microbial infection. "The transferrin family of non-heme iron binding glycoproteins are believed to...

Rabies deaths raise awareness in medical community.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- After an artery infected with rabies led to the death of a transplant patient, health officials have been discussing the possibility of developing a better tracking system for donated vessels. The...

New prostate cancer guidelines validate PSA and free PSA screening tests.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- New guidelines from the independent National Comprehensive Cancer Network (NCCN) strongly support the prostate specific antigen (PSA) and percent-free PSA blood tests to aid in the detection and...

Peoples Genetics' technologies acquired for genetic analyses.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Beckman Coulter, Inc., announced that they have acquired the technologies of Peoples Genetics, Inc., (PGI) of Woburn, Massachusetts. The technologies are used for the comprehensive genetic analysis...

Acquisition of Atto Bioscience made for $25M.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Becton, Dickinson and Company (BD) (BDX), through its BD Biosciences segment, announced that it has acquired Atto Bioscience, Inc., in a cash transaction valued at approximately $25 million. Atto...

Infective endocarditis has a high mortality rate.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Infective endocarditis has a high mortality rate according to a study from North Ireland. "Infective endocarditis, a serious infection of the endocardium of the heart, particularly the heart...

Oxygen sensing in worms may hold key to healthy blood pressure in humans.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- For life on our planet, the rule is simple: If you don't get the right amount of oxygen, you die. For humans, living as we do in an atmosphere with a rich and stable supply of oxygen, maintaining...

New development program signed with Innovata Biomed.
August 4, 2004... 2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Bespak plc (BPK) has signed a key new development agreement with Innovata Biomed Ltd (IB) a provider of inhalation technology, the respiratory division of ML Laboratories PLC that supplies inhaled drug...